Home > Insider Trading > Filing (0000899243-21-042437)

Filing Details

Accession Number:: 0000899243-21-042437
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-11-02 18:45:15
Reporting Period:: 2021-11-01

Accepted Time:: 2021-11-02 18:45:15
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1815442	Kymera Therapeutics Inc.	KYMR	Biological Products, (No Disgnostic Substances) (2836)	812992166

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1821198	Jared Gollob	C/O Kymera Therapeutics, Inc. 200 Arsenal Yards Blvd., Suite 230 Watertown MA 02472	Chief Medical Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2021-11-01	20,000	$1.31	62,547	No	4	M	Direct
Common Stock	Acquisiton	2021-11-01	4,607	$2.08	67,154	No	4	M	Direct
Common Stock	Disposition	2021-11-01	7,387	$60.40	59,767	No	4	S	Direct
Common Stock	Disposition	2021-11-01	15,134	$61.50	44,633	No	4	S	Direct
Common Stock	Disposition	2021-11-01	15,911	$62.34	28,722	No	4	S	Direct
Common Stock	Disposition	2021-11-01	4,065	$63.17	24,657	No	4	S	Direct
Common Stock	Acquisiton	2021-11-02	14,996	$2.08	39,653	No	4	M	Direct
Common Stock	Disposition	2021-11-02	8,514	$62.89	31,139	No	4	S	Direct
Common Stock	Disposition	2021-11-02	5,280	$63.50	25,859	No	4	S	Direct
Common Stock	Disposition	2021-11-02	1,202	$64.34	24,657	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2021-11-01	20,000	$0.00	20,000	$1.31
Common Stock	Stock Option (Right to Buy)	Disposition	2021-11-01	4,607	$0.00	4,607	$2.08
Common Stock	Stock Option (Right to Buy)	Disposition	2021-11-02	14,996	$0.00	14,996	$2.08

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
40,007	2028-10-31	No	4	M	Direct
133,808	2029-05-22	No	4	M	Direct
118,812	2029-05-22	No	4	M	Direct

Footnotes

This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on November 6, 2020.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $60.00 to $60.98. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $61.01 to $62.00. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $62.03 to $63.01. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $63.03 to $63.57. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $62.13 to $63.12. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $63.13 to $64.09. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $64.13 to $64.48. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Twenty-five percent (25%) of the shares underlying this stock option vested on September 12, 2019 and the remaining shall vest in equal monthly installments over the remaining thirty-six (36) months, subject to the reporting person's continued employment through each vesting date.
The shares underlying this stock option shall vest in forty-eight (48) equal monthly installments following the vesting commencement date of February 7, 2019, subject to the reporting person's continued employment through each vesting date.